{"id":55738,"date":"2023-04-12T15:05:37","date_gmt":"2023-04-12T13:05:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/"},"modified":"2023-04-12T15:05:37","modified_gmt":"2023-04-12T13:05:37","slug":"launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/","title":{"rendered":"Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development"},"content":{"rendered":"
\n

\nPartnership optimizes trial planning, driving innovation and efficiency<\/i><\/p>\n

NEW YORK–(BUSINESS WIRE)–#clinicalresearch<\/a>—Medidata<\/a>, a Dassault Syst\u00e8mes company, today announced that Launch Therapeutics<\/a> selected Medidata AI Intelligent Trials<\/a> to support its innovative approach to accelerating clinical trials of late-stage therapies. Launch Therapeutics (Launch Tx) is a clinical development company with a mission to disrupt the late-stage development paradigm, accelerate timelines to regulatory success, and bring new medicines to patients faster.<\/p>\n

<\/a><\/p>\n

\n“Medidata brings expertise, industry leading data, and insights. We are proud to partner with this global leader to help bring fresh approaches to facilitate drug development,” said Elisha Talley-Roithner, executive vice president, Clinical Operations, Launch Tx. \u201cOur industry partners can trust that through our work with Medidata, we are committed to finding solutions that address key industry challenges and advance study timelines.\u201d<\/p>\n

\nMedidata AI Intelligent Trials\u2019 Study Feasibility solution provides Launch Tx with higher assurance that trial planning will improve enrollment and quality. This is done by leveraging country and site-level performance data, and predictive analytics. It\u2019s built on a foundation of industry-leading data from more than 30,000 clinical trials across a wide array of disease indications representing more than nine million study participants.<\/p>\n

\n\u201cLaunch Tx is taking an exciting approach to investing in and driving clinical trial development,\u201d said Fareed Melhem, head of Medidata AI. \u201cAdding unique insights from our Intelligent Trials solution will support their mission to disrupt the late-stage development paradigm.\u201d<\/p>\n

\nMedidata is a wholly owned subsidiary of Dassault Syst\u00e8mes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.<\/p>\n

\nAbout Medidata<\/b><\/p>\n

\nMedidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 2,100+ customers and partners access the world’s most trusted platform for clinical development, commercial, and real-world data. Medidata, a Dassault Syst\u00e8mes company (Euronext Paris: FR0014003TT8, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com<\/a> and follow us @Medidata<\/a>.<\/p>\n

\nAbout Dassault Syst\u00e8mes<\/b><\/p>\n

\nDassault Syst\u00e8mes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production to achieve a more sustainable world for patients, citizens, and consumers. Dassault Syst\u00e8mes brings value to more than 300,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com<\/a>.<\/p>\n

\n3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Syst\u00e8mes, a French \u201csoci\u00e9t\u00e9 europ\u00e9enne\u201d (Versailles Commercial Register # B 322 306 440), or its subsidiaries in the United States and\/or other countries.<\/p>\n

Contacts<\/b> <\/p>\n

\nFor Medidata:
\n
<\/b>Tom Paolella
\n
Senior Director, Corporate Communications & Affairs
\n
+1-848-203-7596
\n
thomas.paolella@3ds.com<\/a><\/p>\n

\nPaul Oestreicher
\n
External Communications Director
\n
+1-917-522-4692
\n
paul.oestreicher@3ds.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Partnership optimizes trial planning, driving innovation and efficiency NEW YORK–(BUSINESS WIRE)–#clinicalresearch—Medidata, a Dassault Syst\u00e8mes company, today announced that Launch Therapeutics selected Medidata AI Intelligent Trials to support its innovative approach to accelerating clinical trials of late-stage therapies. Launch Therapeutics (Launch Tx) is a clinical development company with a mission to disrupt the late-stage development paradigm, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55738","6":"format-standard","7":"category-industry"},"yoast_head":"\nLaunch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Partnership optimizes trial planning, driving innovation and efficiency NEW YORK–(BUSINESS WIRE)–#clinicalresearch—Medidata, a Dassault Syst\u00e8mes company, today announced that Launch Therapeutics selected Medidata AI Intelligent Trials to support its innovative approach to accelerating clinical trials of late-stage therapies. Launch Therapeutics (Launch Tx) is a clinical development company with a mission to disrupt the late-stage development paradigm, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-12T13:05:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230412005119\/en\/1761117\/21\/3DS_MEDIDATA_Logotype_Navy.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development\",\"datePublished\":\"2023-04-12T13:05:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\\\/\"},\"wordCount\":573,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005119\\\/en\\\/1761117\\\/21\\\/3DS_MEDIDATA_Logotype_Navy.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\\\/\",\"name\":\"Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005119\\\/en\\\/1761117\\\/21\\\/3DS_MEDIDATA_Logotype_Navy.jpg\",\"datePublished\":\"2023-04-12T13:05:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005119\\\/en\\\/1761117\\\/21\\\/3DS_MEDIDATA_Logotype_Navy.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005119\\\/en\\\/1761117\\\/21\\\/3DS_MEDIDATA_Logotype_Navy.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/","og_locale":"en_US","og_type":"article","og_title":"Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development - Pharma Trend","og_description":"Partnership optimizes trial planning, driving innovation and efficiency NEW YORK–(BUSINESS WIRE)–#clinicalresearch—Medidata, a Dassault Syst\u00e8mes company, today announced that Launch Therapeutics selected Medidata AI Intelligent Trials to support its innovative approach to accelerating clinical trials of late-stage therapies. Launch Therapeutics (Launch Tx) is a clinical development company with a mission to disrupt the late-stage development paradigm, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-12T13:05:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230412005119\/en\/1761117\/21\/3DS_MEDIDATA_Logotype_Navy.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development","datePublished":"2023-04-12T13:05:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/"},"wordCount":573,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230412005119\/en\/1761117\/21\/3DS_MEDIDATA_Logotype_Navy.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/","url":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/","name":"Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230412005119\/en\/1761117\/21\/3DS_MEDIDATA_Logotype_Navy.jpg","datePublished":"2023-04-12T13:05:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230412005119\/en\/1761117\/21\/3DS_MEDIDATA_Logotype_Navy.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230412005119\/en\/1761117\/21\/3DS_MEDIDATA_Logotype_Navy.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/launch-therapeutics-selects-medidata-ai-intelligent-trials-to-accelerate-clinical-trial-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55738"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55738\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55738"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55738"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}